Bone scintigraphy in osteosarcoma

A single institution experience

Jacquelyn M. Powers, Carrye Cost, Kevin Cederberg, David Leonard, Patrick J. Leavey

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Bone scintigraphy is a well-established method to evaluate for metastatic disease in osteosarcoma. We identified a patient who had a negative (cold) bone scan at skeletal relapse and consequently reviewed the frequency of cold scans in osteosarcoma at our institution. No cold scans were identified at diagnosis, and only 1 patient had a cold scan at skeletal recurrence. No correlation was identified between clinical outcomes and bone scan features, other than identification of metastatic disease. Patients with skeletal recurrence were all symptomatic, thus we suggest that bone scintigraphy is not indicated in routine postchemotherapy surveillance for patients with osteosarcoma.

Original languageEnglish (US)
Pages (from-to)e543-e545
JournalJournal of Pediatric Hematology/Oncology
Volume36
Issue number8
StatePublished - Nov 8 2014

Fingerprint

Osteosarcoma
Radionuclide Imaging
Bone and Bones
Recurrence

Keywords

  • Bone scan
  • Bone scintigraphy
  • Imaging
  • Osteosarcoma

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology
  • Medicine(all)

Cite this

Bone scintigraphy in osteosarcoma : A single institution experience. / Powers, Jacquelyn M.; Cost, Carrye; Cederberg, Kevin; Leonard, David; Leavey, Patrick J.

In: Journal of Pediatric Hematology/Oncology, Vol. 36, No. 8, 08.11.2014, p. e543-e545.

Research output: Contribution to journalArticle

Powers, Jacquelyn M. ; Cost, Carrye ; Cederberg, Kevin ; Leonard, David ; Leavey, Patrick J. / Bone scintigraphy in osteosarcoma : A single institution experience. In: Journal of Pediatric Hematology/Oncology. 2014 ; Vol. 36, No. 8. pp. e543-e545.
@article{55ced83852084d5986d1ea71f9293b62,
title = "Bone scintigraphy in osteosarcoma: A single institution experience",
abstract = "Bone scintigraphy is a well-established method to evaluate for metastatic disease in osteosarcoma. We identified a patient who had a negative (cold) bone scan at skeletal relapse and consequently reviewed the frequency of cold scans in osteosarcoma at our institution. No cold scans were identified at diagnosis, and only 1 patient had a cold scan at skeletal recurrence. No correlation was identified between clinical outcomes and bone scan features, other than identification of metastatic disease. Patients with skeletal recurrence were all symptomatic, thus we suggest that bone scintigraphy is not indicated in routine postchemotherapy surveillance for patients with osteosarcoma.",
keywords = "Bone scan, Bone scintigraphy, Imaging, Osteosarcoma",
author = "Powers, {Jacquelyn M.} and Carrye Cost and Kevin Cederberg and David Leonard and Leavey, {Patrick J.}",
year = "2014",
month = "11",
day = "8",
language = "English (US)",
volume = "36",
pages = "e543--e545",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Bone scintigraphy in osteosarcoma

T2 - A single institution experience

AU - Powers, Jacquelyn M.

AU - Cost, Carrye

AU - Cederberg, Kevin

AU - Leonard, David

AU - Leavey, Patrick J.

PY - 2014/11/8

Y1 - 2014/11/8

N2 - Bone scintigraphy is a well-established method to evaluate for metastatic disease in osteosarcoma. We identified a patient who had a negative (cold) bone scan at skeletal relapse and consequently reviewed the frequency of cold scans in osteosarcoma at our institution. No cold scans were identified at diagnosis, and only 1 patient had a cold scan at skeletal recurrence. No correlation was identified between clinical outcomes and bone scan features, other than identification of metastatic disease. Patients with skeletal recurrence were all symptomatic, thus we suggest that bone scintigraphy is not indicated in routine postchemotherapy surveillance for patients with osteosarcoma.

AB - Bone scintigraphy is a well-established method to evaluate for metastatic disease in osteosarcoma. We identified a patient who had a negative (cold) bone scan at skeletal relapse and consequently reviewed the frequency of cold scans in osteosarcoma at our institution. No cold scans were identified at diagnosis, and only 1 patient had a cold scan at skeletal recurrence. No correlation was identified between clinical outcomes and bone scan features, other than identification of metastatic disease. Patients with skeletal recurrence were all symptomatic, thus we suggest that bone scintigraphy is not indicated in routine postchemotherapy surveillance for patients with osteosarcoma.

KW - Bone scan

KW - Bone scintigraphy

KW - Imaging

KW - Osteosarcoma

UR - http://www.scopus.com/inward/record.url?scp=84918563134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918563134&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - e543-e545

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 8

ER -